| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $103K | — |
| R&D Expense | $3.1M | +75.8% |
| SG&A Expense | $5.7M | +29.5% |
| Operating Income | -$9.0M | -46.1% |
| Interest Expense | $14K | +55.6% |
| Net Income | -$8.9M | -47.3% |
| EPS (Basic) | -$0.67 | -24.1% |
| EPS (Diluted) | -$0.67 | -21.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $432K | -65.2% |
| Short-term Investments | $1.2M | — |
| Accounts Receivable | $4K | — |
| Inventory | $50K | — |
| Current Assets | $783K | -50.9% |
| Total Assets | $2.6M | +8.9% |
| Current Liabilities | $968K | -29.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.9M | -35.9% |
| Capital Expenditures | $11K | +120.0% |
| Investing Cash Flow | -$11K | -120.0% |
| Financing Cash Flow | $6.1M | +21.4% |
| Free Cash Flow | -$7.0M | -36.0% |
| Total Liabilities |
| $968K |
| -31.4% |
| Stockholders' Equity | $1.6M | +151.6% |